MEF2C and acute lymphoblastic leukemia: Patients with early thymocyte progenitor–ALL (ETP-ALL) reflect the most immature T-ALL entity (1) and contain recurrent lesions that activate MEF2C (5, 9) or HOXA genes (6, 9) or that generate PU.1 fusions (7).